At a glance
ClinicalIndex Comparison RecordN/ACompleted· 68 enrolled
Drug / intervention
RetinaVue 100 cameradevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Feasibility Study of Retinal Screening Using the RetinaVue 100 Hand- Held (Non-mydriatic) Camera in Outpatient Dialysis Centers
In Brief
A clinical study evaluating RetinaVue 100 camera for Kidney Failure, Chronic and 2 related conditions. Completed, enrolled 68 participants across 1 site.
Detailed Summary
The purpose of this research study is to look at retinal abnormalities in outpatient renal dialysis patients using the FDA approved RetinaVue 100 hand-held (non-mydriatic) camera.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKidney Failure, Chronic, Eye Diseases, Diabetic Retinopathy
CountriesUnited States
CollaboratorsWelch Allyn
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJul 2016
First PostedJul 2016
Primary CompletionMay 2017
TodayJul 2026
First PostedJul 6, 2016
Enrollment StartJul 1, 2016
Primary CompletionMay 1, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.0 years ago
Interventions
RetinaVue 100 cameradevice
Images of the subject's eye will be obtained using the RetinaVue 100 camera and uploaded to a secure network. The study doctor, a board-certified ophthalmologist, will interpret the patient images and return a diagnosis and management plan to the dialysis unit.